Phase IIb Multicenter Randomized Comparative Study of Anti-pneumococcal Vaccine Strategy in Patients Treated With Immunosuppressants or Biotherapies for Chronic Inflammatory Bowel Disease
Phase of Trial: Phase II
Latest Information Update: 05 Jun 2017
At a glance
- Drugs Pneumococcal 13-valent CRM197 vaccine conjugate (Primary) ; Pneumococcal vaccine
- Indications Pneumococcal infections
- Focus Pharmacodynamics
- Acronyms PneumoMICI
- 17 May 2016 Planned End Date changed from 1 Dec 2017 to 1 Dec 2020.
- 17 May 2016 Planned primary completion date changed from 1 Apr 2016 to 1 Dec 2020.
- 14 Apr 2015 Planned primary completion date changed from 1 Oct 2015 to 1 Apr 2016, according to CinicalTrials.gov record.